Nutrien Ltd. (NTR) Key Metrics
NTR valuation today
Trailing 12 months · as of October 17, 2026- Market cap
- $34.01B
- Enterprise value
- $47.93B
- P/E (TTM)
- 14.4 10-yr median 17.9
- Forward P/E
- 14.7
- PEG ratio
- 1.98
- Price / sales
- 1.2 10-yr median 1.2
- Price / book
- 1.4 10-yr median 1.2
- EV / EBITDA
- 7.6 10-yr median 8.1
- Dividend yield
- 3.09% $2.20 a year
- Beta
- 1.13
NTR key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsNTR valuation Price multiples at each fiscal year-end price.
NTR returns How much profit the business earns on the capital it uses.
NTR per-share figures Results divided by the shares outstanding at year-end.
NTR financial health Debt, liquidity and how easily interest is covered.
NTR efficiency & capital use Working capital cycle and where the cash goes.
NTR valuation history
NTR returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
NTR debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
NTR cash returned to shareholders
NTR price vs earnings per share
NTR key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $30.03B | $22.12B | $28.00B | $39.44B | $42.96B | $27.44B | $27.94B | $29.37B | — | — |
| Enterprise value | $42.26B | $34.08B | $39.62B | $50.46B | $53.31B | $37.34B | $38.37B | $36.28B | — | — |
| P/E ratio | 13.2 | 32.8 | 22.3 | 5.1 | 13.6 | 59.8 | 28.2 | 8.2 | — | — |
| Price / sales | 1.1 | 0.9 | 1.0 | 1.0 | 1.6 | 1.3 | 1.4 | 1.5 | — | — |
| Price / book | 1.2 | 0.9 | 1.1 | 1.5 | 1.8 | 1.2 | 1.2 | 1.2 | — | — |
| Price / free cash flow | 14.7 | 16.0 | 11.4 | 7.0 | 20.4 | 15.5 | 15.7 | 53.9 | — | — |
| Price / operating cash flow | 7.4 | 6.3 | 5.5 | 4.9 | 11.1 | 8.3 | 7.6 | 14.3 | — | — |
| EV / sales | 1.6 | 1.3 | 1.4 | 1.3 | 1.9 | 1.8 | 1.9 | 1.8 | — | — |
| EV / EBITDA | 6.9 | 8.1 | 8.1 | 3.9 | 8.1 | 12.9 | 10.5 | 17.9 | — | — |
| EV / free cash flow | 20.7 | 24.7 | 16.1 | 8.9 | 25.3 | 21.0 | 21.6 | 66.6 | — | — |
| Earnings yield | 7.5% | 3.0% | 4.5% | 19.4% | 7.3% | 1.7% | 3.6% | 12.2% | — | — |
| Free cash flow yield | 6.8% | 6.2% | 8.8% | 14.4% | 4.9% | 6.5% | 6.4% | 1.9% | — | — |
| Dividend yield | 3.6% | 4.8% | 3.7% | 2.6% | 2.4% | 3.8% | 3.7% | 3.2% | — | — |
| Shareholder yield (dividends + buybacks) | 5.5% | 5.6% | 7.4% | 14.1% | 4.8% | 4.3% | 10.6% | 9.4% | — | — |
| Share price at fiscal year-end | $61.72 | $44.75 | $56.33 | $73.03 | $75.20 | $48.16 | $47.91 | $47.00 | — | — |
| Per share | ||||||||||
| Revenue per share | $55.26 | $52.54 | $58.46 | $70.15 | $48.51 | $36.70 | $34.44 | $31.42 | $13.53 | $13.27 |
| Earnings per share | $4.66 | $1.36 | $2.53 | $14.18 | $5.52 | $0.81 | $1.70 | $5.72 | $0.97 | $1.00 |
| Operating cash flow per share | $8.38 | $7.15 | $10.19 | $15.02 | $6.80 | $5.83 | $6.29 | $3.28 | $3.64 | $3.75 |
| Free cash flow per share | $4.19 | $2.79 | $4.96 | $10.50 | $3.68 | $3.11 | $3.04 | $0.87 | $1.71 | $1.09 |
| Cash per share | $1.44 | $1.73 | $1.89 | $1.67 | $0.87 | $2.55 | $1.15 | $3.70 | $0.35 | $0.10 |
| Book value per share | $51.95 | $49.37 | $50.62 | $47.81 | $41.40 | $39.26 | $39.22 | $39.09 | $24.70 | $24.46 |
| Tangible book value per share | $23.64 | $21.33 | $21.78 | $20.65 | $15.91 | $13.65 | $14.50 | $17.26 | $24.21 | $23.92 |
| Dividends per share | $2.22 | $2.14 | $2.08 | $1.91 | $1.83 | $1.81 | $1.75 | $1.52 | $0.98 | $2.41 |
| Capex per share | $4.19 | $4.36 | $5.23 | $4.51 | $3.12 | $2.72 | $3.24 | $2.41 | $1.94 | $2.66 |
| Debt per share | $26.58 | $25.91 | $25.28 | $22.09 | $18.99 | $19.94 | $19.04 | $14.76 | $13.21 | $13.67 |
| Shares outstanding | 486.5M | 494.4M | 497.0M | 540.0M | 571.3M | 569.7M | 583.1M | 624.9M | 336.1M | 335.8M |
| Change in shares outstanding | −1.6% | −0.5% | −8.0% | −5.5% | +0.3% | −2.3% | −6.7% | +85.9% | +0.1% | +0.3% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | 9.1% | 2.7% | 4.9% | 31.0% | 13.7% | 2.0% | 4.2% | 21.8% | 4.0% | 4.0% |
| Return on invested capital (ROIC) | 7.9% | 5.0% | 6.9% | 22.9% | 11.0% | 2.8% | 4.4% | 1.5% | 1.3% | 3.0% |
| Return on assets (ROA) | 4.4% | 1.3% | 2.3% | 14.7% | 6.5% | 1.0% | 2.1% | 11.4% | 1.9% | 1.9% |
| Return on tangible assets | 5.9% | 1.8% | 3.3% | 19.2% | 8.9% | 1.4% | 3.1% | 11.2% | 1.9% | 2.0% |
| Free cash flow margin | 7.6% | 5.3% | 8.5% | 15.0% | 7.6% | 8.5% | 8.8% | 2.8% | 12.6% | 8.2% |
| Income quality (OCF / net income) | 1.80 | 5.24 | 4.03 | 1.06 | 1.23 | 7.24 | 3.69 | 0.57 | 3.75 | 3.75 |
| Financial health | ||||||||||
| Total debt | $12.93B | $12.81B | $12.57B | $11.93B | $10.85B | $11.36B | $11.10B | $9.22B | $4.44B | $4.59B |
| Cash & short-term investments | $699.7M | $853.0M | $941.0M | $901.0M | $499.0M | $1.45B | $671.0M | $2.31B | $116.0M | $32.0M |
| Net debt | $12.23B | $11.95B | $11.62B | $11.03B | $10.35B | $9.91B | $10.43B | $6.91B | $4.33B | $4.56B |
| Debt / equity | 0.51 | 0.52 | 0.50 | 0.46 | 0.46 | 0.51 | 0.49 | 0.38 | 0.53 | 0.56 |
| Debt / assets | 0.25 | 0.25 | 0.24 | 0.22 | 0.22 | 0.24 | 0.24 | 0.20 | 0.26 | 0.27 |
| Net debt / EBITDA | 1.99 | 2.84 | 2.38 | 0.86 | 1.57 | 3.43 | 2.85 | 3.42 | 4.79 | 3.94 |
| Current ratio | 1.34 | 1.15 | 1.17 | 1.14 | 1.11 | 1.35 | 1.17 | 1.40 | 2.07 | 0.82 |
| Quick ratio | 0.70 | 0.63 | 0.65 | 0.61 | 0.60 | 0.77 | 0.62 | 0.81 | 1.58 | 0.37 |
| Interest coverage | 5.3 | 4.5 | 4.8 | 20.4 | 10.1 | 1.7 | 3.3 | 0.7 | 0.9 | 2.1 |
| Working capital | $3.70B | $1.75B | $2.05B | $2.06B | $1.40B | $2.99B | $1.54B | $3.33B | $1.72B | −$303.0M |
| Invested capital | $37.51B | $36.36B | $36.78B | $36.84B | $34.00B | $32.27B | $33.30B | $31.33B | $12.63B | $12.77B |
| Tangible asset value | $11.54B | $10.58B | $10.87B | $11.20B | $9.14B | $7.82B | $8.46B | $10.78B | $8.14B | $8.04B |
| Net current asset value | −$12.16B | −$13.61B | −$13.38B | −$12.38B | −$12.41B | −$13.32B | −$13.27B | −$9.41B | −$5.37B | −$7.66B |
| Graham number | $73.80 | $38.92 | $53.69 | $123.53 | $71.70 | $26.68 | $38.75 | $70.91 | $23.25 | $23.47 |
| Graham net-net per share | −$37.94 | −$39.30 | −$40.12 | −$36.68 | −$33.37 | −$32.66 | −$31.70 | −$22.80 | −$23.48 | −$24.78 |
| Capital allocation | ||||||||||
| Dividends paid | $1.08B | $1.06B | $1.03B | $1.03B | $1.04B | $1.03B | $1.02B | $952.0M | $330.0M | $809.0M |
| Share buybacks (net) | $560.6M | $184.0M | $1.05B | $4.52B | $1.03B | $160.0M | $1.93B | $1.80B | $0 | $0 |
| Dividend payout ratio | 47.6% | 157.3% | 82.0% | 13.5% | 33.1% | 224.4% | 103.0% | 26.6% | 100.9% | 240.8% |
| Dividends + buybacks / free cash flow | 80.5% | 90.1% | 84.3% | 97.9% | 98.9% | 67.1% | 166.4% | 505.0% | 57.5% | 220.4% |
| Capex / revenue | 7.6% | 8.3% | 8.9% | 6.4% | 6.4% | 7.4% | 9.4% | 7.7% | 14.3% | 20.0% |
| Capex / operating cash flow | 50.0% | 60.9% | 51.3% | 30.1% | 45.9% | 46.6% | 51.6% | 73.4% | 53.1% | 70.9% |
| Capex / depreciation | 0.86 | 0.92 | 1.20 | 1.21 | 0.91 | 0.78 | 1.05 | 0.95 | 0.94 | 1.28 |
| Stock-based compensation / revenue | 0.6% | 0.1% | −0.0% | 0.2% | 0.7% | 0.3% | 0.5% | 0.6% | 0.2% | 0.0% |
| R&D / revenue | — | 0.5% | 0.4% | 0.3% | 0.2% | 0.2% | 0.1% | 0.0% | — | — |
| SG&A / revenue | 15.3% | 16.1% | 14.0% | 10.8% | 13.8% | 15.8% | 15.0% | 14.6% | 4.7% | 4.8% |
| Efficiency | ||||||||||
| Days sales outstanding | 75.0 | 70.7 | 64.5 | 49.6 | 50.9 | 52.9 | 52.6 | 29.1 | 32.8 | 36.7 |
| Days of inventory on hand | 129.1 | 123.5 | 123.9 | 113.4 | 112.3 | 115.4 | 123.8 | 73.1 | 73.7 | 76.4 |
| Days payables outstanding | 144.2 | 107.2 | 100.0 | 89.2 | 95.7 | 98.2 | 88.5 | 42.4 | 28.2 | 38.6 |
| Cash conversion cycle (days) | 59.9 | 87.0 | 88.4 | 73.9 | 67.5 | 70.1 | 88.0 | 59.9 | 78.3 | 74.5 |
| Receivables turnover | 4.86 | 5.16 | 5.66 | 7.36 | 7.18 | 6.89 | 6.93 | 12.52 | 11.13 | 9.96 |
| Payables turnover | 2.53 | 3.40 | 3.65 | 4.09 | 3.82 | 3.72 | 4.13 | 8.61 | 12.95 | 9.47 |
| Inventory turnover | 2.83 | 2.95 | 2.95 | 3.22 | 3.25 | 3.16 | 2.95 | 4.99 | 4.95 | 4.78 |
| Asset turnover | 0.52 | 0.50 | 0.54 | 0.72 | 0.57 | 0.44 | 0.44 | 0.63 | 0.27 | 0.26 |
| Average receivables | $5.53B | $5.03B | $5.13B | $5.15B | $3.86B | $3.03B | $2.90B | $1.57B | $408.5M | $447.5M |
| Average payables | $7.33B | $5.42B | $5.64B | $5.49B | $4.80B | $4.22B | $3.53B | $1.65B | $297.5M | $383.0M |
| Average inventory | $6.56B | $6.24B | $6.98B | $6.98B | $5.63B | $4.95B | $4.95B | $2.85B | $778.0M | $758.5M |
| Intangibles / total assets | 26.4% | 26.7% | 27.2% | 26.9% | 29.1% | 30.9% | 30.8% | 30.0% | 1.0% | 1.0% |
Computed from NTR's annual financial statements (latest annual report filed February 27, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
NTR valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), Nutrien traded at 13.2 times earnings, against a 10-year median of 17.9. Based on the latest twelve months, the trailing P/E is 14.4 and the forward P/E is 14.7. Nutrien earned a return on equity of 9.1% and a return on invested capital of 7.9% in fiscal 2025. It ended the year with $12.9 billion of debt and $699.7 million in cash and short-term investments, net debt of $12.2 billion. It returned $1.6 billion to shareholders: $1.1 billion in dividends and $560.6 million in share buybacks, 81% of free cash flow. The share count rose 44.9% from 335.8M to 486.5M over 9 years.
See the NTR income statement, the NTR chart for price history, or the NTR stock overview for the latest quote and news.
NTR key metrics FAQ
What is Nutrien's P/E ratio?
Nutrien's trailing P/E ratio is 14.4 based on the last twelve months of earnings (as of October 17, 2026), and its forward P/E is 14.7. At the end of fiscal 2025 it was 13.2, compared with a 10-year median of 17.9.
What is Nutrien's EV/EBITDA?
Nutrien's enterprise value was 6.9 times EBITDA at the end of fiscal 2025 (enterprise value $42.3 billion, EBITDA $6.1 billion); the current EV/EBITDA is 7.6.
What is Nutrien's return on equity?
Nutrien's return on equity (ROE) was 9.1% in fiscal 2025: net income of $2.3 billion on average shareholders' equity of $24.8 billion.
What is Nutrien's ROIC?
Nutrien's return on invested capital was 7.9% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Nutrien have?
Nutrien had total debt of $12.9 billion at the end of fiscal 2025, a debt-to-equity ratio of 0.51 and $12.2 billion of net debt (1.99 times EBITDA).
What is Nutrien's dividend yield?
Nutrien's forward dividend yield is 3.09%. Nutrien paid $1.1 billion in dividends in fiscal 2025 ($2.22 per share), a payout ratio of 47.6%.
Does Nutrien buy back its shares?
Yes. Nutrien spent $560.6 million on net share repurchases in fiscal 2025 Shares outstanding changed −1.6% over the year, to 486.5M..
What is Nutrien's free cash flow yield?
Nutrien generated $2.0 billion of free cash flow in fiscal 2025, a free cash flow yield of 6.8% on its market value at year-end ($30.0 billion).
What is Nutrien's current ratio?
Nutrien's current ratio was 1.34 at the end of fiscal 2025: current assets were 1.34 times current liabilities.